Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Global Molecular Breast Imaging Market Snapshot (2023 to 2033)

The global molecular breast imaging market was valued at US$ 846.7 Million in 2022 and is expected to reach US$ 1.4 Billion by 2033. The screening application with around 56.7% value share, has topped the global market within the application category in 2022 and is expected to grow at a CAGR of close to 4.7% over the forecast period (2023-2033)

Market Outlook-

Key Market Attributes

Market Size, 2022 US$ 846.7 Million
Market Size, 2023 US$ 883.4 Million
Market Size, 2033 US$ 1.4 Billion
Value CAGR (2023 to 2033) 4.8%

Molecular breast imaging (MBI), also known as breasts specific gamma imaging (BSGI), is a diagnostic imaging modality using gamma cameras and radiopharmaceutical to identify breast cancer. Its uptake is influenced by factors like blood flow, mitochondrial activity, and physiologic factors.

  • MBI has a high sensitivity of 89%-96.4%, comparable to Magnetic Resonance Imaging (MRI), and can detect high-risk lesions like atypical ductal hyperplasia (ADH) and atypical lobular hyperplasia (ALH) (NCBI, 2023- Study on Invasive Lobular Carcinoma).

Although not recommended for generalized screening, MBI is suitable for diagnostic evaluation, patients with contraindications to MRI, newly diagnosed breast cancer, and women with dense breast tissue.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Analysis of Historical and Future Outlooks Molecular Breast Imaging Market

The global market for molecular breast imaging was around 18.6% of the overall US$ 4.55 Billion of the global breast imaging market in 2022.

Semi Annual Market Update

Particular Value CAGR
H1 4.27% (2022 to 2032)
H2 5.24% (2022 to 2032)
H1 3.85% (2023 to 2033)
H2 5.68% (2023 to 2033)

MBI can reliably image subcentimeter cancers and produce projections similar to mammography, making it more integrated into clinical practice. There are various configurations of breast-specific gamma cameras, including single-headed and dual-headed models.

MBI involves injecting radiopharmaceutial technetium-99m sestimibi, Miraluma, into the venous system, and the patient is positioned while seated with the breast compressed between the detector and compression plate or two detectors in a dual-headed camera. The radiologist reviews initial images and can acquire additional images as needed.

Owed to the above factors, the global market is projected to grow at CAGR of 4.8% in forecasted period.

Brief Outlook on Key Opportunities for Molecular Breast Imaging Service Provider

The molecular breast imaging (MBI) market is expected to grow due to the growing prevalence of dense breast tissue within the screening population, affecting large patient pool.

  • In a study published by American Association for Cancer Research - 2021, based on the Breast Imaging Reporting and Data System (BI-RADS) for breast composition classification, it was estimated that around 40 to 50% of women in the United States who have been receiving mammogram are likely to have mamographically dense breasts.

Traditional breast cancer detection methods, like mammography, are sensitivity-limited, causing false-negative results for individuals with dense breasts. MBI offers a promising solution for millions of individuals with dense breasts, offering high detection rates and negative predictive value as per Journal of Nuclear Medicine- Official Publication, Society of Nuclear Medicine 2022. It offers advantages over other supplemental screening methods like breast MRI, whole-breast ultrasound, and contrast-enhanced mammography.

With its safety, affordability, ease of access, quick imaging acquisition and interpretation times, and acceptable rates of false-positive findings, MBI is likely to witness increasing adoption in the market. Healthcare providers and patients alike are recognizing the benefits of this technology, leading to a higher demand for MBI systems and services.

The molecular breast imaging (MBI) market is poised for substantial growth due to its potential to significantly improve breast cancer detection rates while minimizing associated risks. Recent studies have demonstrated that the estimated benefit of MBI, in terms of deaths averted, far outweighs the estimated risk of lives lost, with the benefit-to-radiation risk ratio now approaching that of mammography. This critical finding instils confidence in the safety and efficacy of MBI as a powerful screening tool.

One of the key factors driving the market's expansion is the promising data from the prospective multicenter Density MATTERS trial (NCBI, 2022). This study compared MBI with tomosynthesis as a supplemental screening method for women with dense breasts. The results revealed an impressive incremental cancer detection rate of 9.3 per 1,000 screened. Such a high detection rate is a compelling indicator of MBI's superior capability to identify breast cancer, particularly in women with dense breast tissue, where traditional screening methods like mammography may have limitations.

Given these significant advancements and the robust evidence supporting MBI's benefits, the demand for molecular breast imaging technologies is expected to soar. Healthcare providers and patients alike are increasingly recognizing the value of MBI in improving early cancer detection, leading to better treatment outcomes and potentially saving lives.

As the awareness of MBI's advantages spreads, more medical facilities are likely to adopt this cutting-edge technology, fostering the growth of the MBI market and, more importantly, contributing to better breast cancer care worldwide.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Overview of Factors Restraining the Demand for the Molecular Breast Imaging

MBI may require tiled image acquisitions if the breast size exceeds the field of view, making lesions near the chest wall and axillary lymph nodes difficult to visualize. MBI should not be scheduled within 4 half-lives of other 99mTc-based studies, positron emission tomography (PET) / computerized tomography (CT), or targeted radionuclide therapies due to photon energy window overlap.

However, it has limitations such as 28 to 40 minutes of an imaging examination, higher whole-body radiation exposure variable insurance coverage, the need for nuclear medicine licensing and coordination, and lack of widespread availability.

Further, The American College of Radiology does not currently recommend MBI for breast cancer imaging as an adjunctive breast cancer screening basis breast density.

These constraints underscore the difficulties that the molecular breast imaging market is facing.

Country-wise Insights

Market Growth Outlook by Key Countries

Country Value CAGR
United States 4.5%
Germany 5.8%
United Kingdom 5.1%
Japan 5.0%
China 5.1%
India 4.9%

United States - a Prominent Market for Molecular Breast Imaging Globally

The United States occupies 30.9% value share in 2022 globally.

The United States has large population suffering from breast cancer as well as those with dense breast tissue.

  • Dense breast tissue affects 43% of the United States screening population, lowering sensitivity for breast cancer diagnosis (NCBI, 2022).

Growing efficiency of MBI backed by factors such as low false-positive rates, good recall rates, quick interpretation times, a low cost, minimal contraindications, and a strong negative predictive value has increased its demand for breast cancer screening in the United States. Thus making United States a prominent market for molecular breast imaging in North America region

  • As per Journal of Nuclear Medicine- Official Publication, Society of Nuclear Medicine 2023, MBI offers 5–9 times more benefit than mammography in supplementary screening, helping 16-20 million people with thick breasts at risk of false-negative findings.

Germany - a Highly Lucrative Market for Molecular Breast Imaging

Germany occupies 23.1% value share in 2022 with Europe. Expenditure on molecular breast imaging in 2022 was US$ 57.5 Million.

The current age-based mammographic breast cancer screening recommendation in Germany is for women aged 50-69, although new recommendations advise screening decisions should be based on individual risk.

  • According to a Cancer prevention research (Philadelphia, Pa.) 2021 study, 10,498,000 women aged 50 to 69 are eligible for screening, with 39,000 women aged 40 to 49 also eligible. The number required to identify one breast cancer case was 282, which was the same for all 50-69 women.

Longer screening intervals may be suggested for low-risk women to minimize needless diagnostic procedures. Risk-adapted mammographic screening might help high-risk women while lowering expenses and stress on low-risk women. As a result, Germany tends to be a lucrative market for the molecular breast imaging industry.

China - a Large Market for Molecular Breast Imaging

In 2022, the China held a dominant stance in the East Asian market and contributed around US$ 54.9 Million.

  • According to GLOBOCAN 2020, In China, breast cancer is the most prevalent cancer among women, with 416,371 new cases and 117,174 deaths in 2020.

Chinese patients have a younger median age of onset, resulting in longer follow-up and treatment periods. This increases the disease burden for individuals and society. Chinese women undergo breast cancer screening earlier to reduce disease burden and improve prognosis. China updates guidelines, conducts large-scale cohort studies, and standardized screenings. This will significantly increase survival and reduce mortality in the Chinese population. This makes China a large market for molecular breast imaging.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Insight into Leading Modality Impacting Global Market Expansion

Market Growth Outlook by Key Modality

Modality Value CAGR
Single Head Gamma Camera 5.1%
Dual Head Camera 4.6%

By modality, dual head camera covered 61.4% of global market share in 2022.

The dual-head system allows for simultaneous capture of breast images in the craniocaudal, medial, and lateral regions. The sensitivity of dual-head molecular breast imaging for tumors larger than 10 mm in diameter varies the most across blinded assessors. With the addition of the second detector head, the sensitivity for the tiniest breast cancers (diameters 5 mm) is improved. Thus, dual head camera are predicted to expand rapidly between 2023 and 2033.

Analysis of Key Application Leading the Molecular Breast Imaging Market

Market Growth Outlook by Key Applications

Application Value CAGR
Screening 4.7%
Diagnosis 5.0%

The market value of screening application in molecular breast imaging market is US$ 480.1 Million, representing for a sizable 56.7% market share in 2022.

MBI is a highly sensitive imaging technique that can detect breast cancer even in dense breast tissue. It has been shown to be more effective in detecting small tumours and lesions that may not be visible on mammogram. MBI has lower false-positive rate compared to other imaging modalities, such as MRI or ultrasound. This means that fewer women may be subjected to unnecessary follow-up tests or biopsies.

It offers a more comprehensive and accurate assessment of breast health, especially for women with dense breasts or other risk factors. It can be a valuable addition to the standard breast cancer screening protocols, improving early detection and potentially saving lives.

Overview of Key End User Benefiting the Global Market

Market Growth Outlook by Key End Users

End Users Value CAGR
Hospital 4.3%
Diagnostic Imaging Centers 4.8%
Breast Cancer Care 5.8%

The hospitals have a considerable presence in the molecular breast imaging market, accounting for 41.4% of end users in 2022, and exhibiting a CAGR of 4.3% over the forecast period.

Hospitals have access to state-of-art imaging equipment, including specialized molecular breast imaging machines. This ensures that patients receive the most accurate and reliable imaging results for early detection and diagnosis of breast cancer. Hospitals often conduct clinical trials and research studies related to breast cancers and imaging technologies. It provides a holistic approach to breast cancer care, making it the preferred choice for end users in molecular breast imaging.

Competitive Landscape

Innovations and acquisitions among healthcare providers, research institutions, and technology businesses can encourage innovation and hasten molecular breast imaging. Collaboration in research, development, and commercialization leads to market expansion and the creation of new applications. Numerous large firms compete in the field of molecular breast imaging. Among the well-known players in this field are-

  • In March 2023, Philips introduces the Zenition 10 image-guided therapy system, a low-cost, high-quality system using flat panel detector technology for improved patient outcomes in surgical care, trauma, and orthopaedics.
  • In July 2021, Fujifilm Healthcare Europe acquired Hitachi Diagnostic Imaging for 179 billion yen in March 2021, offering comprehensive clinical solutions in CT, MRI, ultrasound, x-ray, women's health, AI, PACS, and IVD.

Similarly, recent developments related to the companies active within the molecular breast imaging market have been tracked by the team at Future Market Insights, which are available in the full report.

Related Market Growth Outlook Scenario

Particulars Value CAGR
Breast Cancer Drugs Market 1.1%
Breast Biopsy Devices Market 5.4%
Breast Lesion Localization Devices Market 5.4%

Report Scope as Per Molecular Breast Imaging Industry Analysis

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis US$ Million for Value, Units for Volume
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA)
Key Countries Covered United States, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, Nordics, China, Japan, South Korea, India, Indonesia, Thailand, Philippines, Malaysia, Vietnam Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa.
Key Market Segments Covered Modality, Application, End User, and Region
Key Companies Profiled
  • Koninklijke Philips N.V. (Netherlands)
  • Hitachi Ltd. (Japan)
  • Siemens Healthcare GmbH (Germany)
  • CANON MEDICAL SYSTEMS CORPORATION (Japan)
  • General Electric (US)
  • Aspect Imaging Ltd (Israel)
  • Bruker (US),
  • Aurora Health Care (US)
  • FONAR Corp. (US)
  • ESAOTE SPA (Italy)
  • Neusoft Corporation (China)
  • TOSHIBA CORPORATION (Japan)
  • Sanrad Medical Systems Private Limited (India)
  • FUJIFILM Holdings Corporation (Japan)
  • ONEX Corporation (Canada)
  • Hologic, Inc. (US)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Imaging Diagnostic Systems, Inc. (US)
  • Agfa-Gevaert Group (Belgium)
  • Koning Health (China)
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Pricing Available upon Request

Key Market Segments Covered in the Molecular Breast Imaging Industry Research

By Modality:

  • Single Head Gamma Camera
  • Dual Head Camera

By Application:

  • Screening
  • Diagnosis

By End User:

  • Hospital
  • Diagnostic Imaging Centers
  • Breast Cancer Care

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

How much is the global market worth in 2022?

The global market is worth US$ 846.7 Million in 2022.

What is the global market estimated to reach by 2023?

The global market estimates for 2023 is around US$ 883.4 Million.

What is the sales forecast for the global market through 2033?

The global market is expected to reach US$ 1.4 Billion by the end of 2033, with a sales revenue expected to register 4.8% CAGR.

What was the last five years’ growth rate for molecular breast imaging market?

The global market grew at a CAGR of 3.9% between 2017 and 2022.

What is the United States market outlook for the molecular breast imaging?

The United States dominated the global market contributing around US$ 262.0 Million in the year 2022.

How much is the Germany’s market worth in 2022?

Germany holds nearly 6.8% market share in the global market in 2022.

What is the outlook of the China market?

China accounted for a market value share of around 6.5% in 2022, in the global market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply-Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Value Added Insights

    4.1. Modality Adoption/Usage Analysis

    4.2. Products USP/ Features Analysis

    4.3. Cancer Statistics, By Key Countries

    4.4. Disease Epidemiology

    4.5. Clinical Applications of Imaging Techniques in Diagnosis

    4.6. Regulatory Landscape

        4.6.1. Regulatory Frameworks in United States

        4.6.2. Regulatory Frameworks in Europe

        4.6.3. Regulatory Frameworks in India

        4.6.4. Regulatory Frameworks in Australia

    4.7. Porter’s Analysis

    4.8. PESTLE Analysis

    4.9. Value Chain Analysis

    4.10. Unmet Needs

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global Healthcare Expenditure

        5.1.2. Global Life Expectancy Market Outlook

        5.1.3. Research and Development funding by Region

        5.1.4. Global Breast Imaging Market Overview – Parent Market Analysis

    5.2. Forecast Factors - Relevance and Impact

        5.2.1. Top Companies Historical Growth

        5.2.2. Increased Prevalence of Chronic Diseases

        5.2.3. Technological Advancements in Molecular Diagnostics

        5.2.4. New Product Launches

        5.2.5. Increasing Focus on Cancer Diagnostics

        5.2.6. Strategic Collaborations and Partnerships

        5.2.7. Cost of Product

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Market Demand (in Volume) Analysis 2017 to 2022 and Forecast, 2023 to 2033

    6.1. Historical Market Volume (Units) Analysis, 2017 to 2022

    6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market – Pricing Assessment

    7.1. Regional Pricing Analysis

    7.2. Pricing Break-up

    7.3. Global Average Pricing Analysis Benchmark

    7.4. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033

    8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022

    8.2. Current and Future Market Size (US$ Million) Projections, 2023 to 2033

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

    8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic

9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Modality

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Modality, 2017 to 2022

    9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Modality, 2023 to 2033

        9.3.1. Single Head Gamma Camera

        9.3.2. Dual Head Camera

    9.4. Market Attractiveness Analysis By Modality

10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        10.3.1. Screening

        10.3.2. Diagnosis

    10.4. Market Attractiveness Analysis By Application

11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        11.3.1. Hospitals

        11.3.2. Diagnostic Imaging Centers

        11.3.3. Breast Cancer Care

    11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2017 to 2022

    12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. South Asia

        12.3.5. East Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa

    12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022

    13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        13.3.1. By Country

            13.3.1.1. United States

            13.3.1.2. Canada

        13.3.2. By Modality

        13.3.3. By Application

        13.3.4. By End User

    13.4. Market Attractiveness Analysis By Region

        13.4.1. By Country

        13.4.2. By Modality

        13.4.3. By Application

        13.4.4. By End User

    13.5. Market trends

    13.6. Key Market Participants - Intensity Mapping

    13.7. Drivers and Restraints - Impact Analysis

    13.8. Country Level Analysis and Forecast

        13.8.1. United States Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast by Market Taxonomy

                13.8.1.2.1. By Modality

                13.8.1.2.2. By Application

                13.8.1.2.3. By End User

        13.8.2. Canada Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast by Market Taxonomy

                13.8.2.2.1. By Modality

                13.8.2.2.2. By Application

                13.8.2.2.3. By End User

14. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022

    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Modality

        14.3.3. By Application

        14.3.4. By End User

    14.4. Market Attractiveness Analysis By Region

        14.4.1. By Country

        14.4.2. By Modality

        14.4.3. By Application

        14.4.4. By End User

    14.5. Market trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country Level Analysis and Forecast

        14.8.1. Brazil Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Modality

                14.8.1.2.2. By Application

                14.8.1.2.3. By End User

        14.8.2. Mexico Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Modality

                14.8.2.2.2. By Application

                14.8.2.2.3. By End User

        14.8.3. Argentina Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast by Market Taxonomy

                14.8.3.2.1. By Modality

                14.8.3.2.2. By Application

                14.8.3.2.3. By End User

15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    15.1. Introduction / Key Findings

    15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. United Kingdom

            15.3.1.2. Germany

            15.3.1.3. Italy

            15.3.1.4. France

            15.3.1.5. Spain

            15.3.1.6. Russia

            15.3.1.7. Nordic Countries

            15.3.1.8. BENELUX

            15.3.1.9. Rest of Europe

        15.3.2. By Modality

        15.3.3. By Application

        15.3.4. By End User

    15.4. Market Attractiveness Analysis By Region

        15.4.1. By Country

        15.4.2. By Modality

        15.4.3. By Application

        15.4.4. By End User

    15.5. Market trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis and Forecast

        15.8.1. United Kingdom Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Modality

                15.8.1.2.2. By Application

                15.8.1.2.3. By End User

        15.8.2. Germany Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Modality

                15.8.2.2.2. By Application

                15.8.2.2.3. By End User

        15.8.3. Italy Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast by Market Taxonomy

                15.8.3.2.1. By Modality

                15.8.3.2.2. By Application

                15.8.3.2.3. By End User

        15.8.4. France Market Analysis

            15.8.4.1. Introduction

            15.8.4.2. Market Analysis and Forecast by Market Taxonomy

                15.8.4.2.1. By Modality

                15.8.4.2.2. By Application

                15.8.4.2.3. By End User

        15.8.5. Spain Market Analysis

            15.8.5.1. Introduction

            15.8.5.2. Market Analysis and Forecast by Market Taxonomy

                15.8.5.2.1. By Modality

                15.8.5.2.2. By Application

                15.8.5.2.3. By End User

        15.8.6. Russia Market Analysis

            15.8.6.1. Introduction

            15.8.6.2. Market Analysis and Forecast by Market Taxonomy

                15.8.6.2.1. By Modality

                15.8.6.2.2. By Application

                15.8.6.2.3. By End User

        15.8.7. Nordic Countries Market Analysis

            15.8.7.1. Introduction

            15.8.7.2. Market Analysis and Forecast by Market Taxonomy

                15.8.7.2.1. By Modality

                15.8.7.2.2. By Application

                15.8.7.2.3. By End User

        15.8.8. BENELUX Market Analysis

            15.8.8.1. Introduction

            15.8.8.2. Market Analysis and Forecast by Market Taxonomy

                15.8.8.2.1. By Modality

                15.8.8.2.2. By Application

                15.8.8.2.3. By End User

16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    16.1. Introduction / Key Findings

    16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Indonesia

            16.3.1.3. Thailand

            16.3.1.4. Philippines

            16.3.1.5. Malaysia

            16.3.1.6. Vietnam

            16.3.1.7. Rest of South Asia

        16.3.2. By Modality

        16.3.3. By Application

        16.3.4. By End User

    16.4. Market Attractiveness Analysis By Region

        16.4.1. By Country

        16.4.2. By Modality

        16.4.3. By Application

        16.4.4. By End User

    16.5. Market trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis and Forecast

        16.8.1. India Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Modality

                16.8.1.2.2. By Application

                16.8.1.2.3. By End User

        16.8.2. Indonesia Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Modality

                16.8.2.2.2. By Application

                16.8.2.2.3. By End User

        16.8.3. Thailand Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast by Market Taxonomy

                16.8.3.2.1. By Modality

                16.8.3.2.2. By Application

                16.8.3.2.3. By End User

        16.8.4. Philippines Market Analysis

            16.8.4.1. Introduction

            16.8.4.2. Market Analysis and Forecast by Market Taxonomy

                16.8.4.2.1. By Modality

                16.8.4.2.2. By Application

                16.8.4.2.3. By End User

        16.8.5. Malaysia Market Analysis

            16.8.5.1. Introduction

            16.8.5.2. Market Analysis and Forecast by Market Taxonomy

                16.8.5.2.1. By Modality

                16.8.5.2.2. By Application

                16.8.5.2.3. By End User

        16.8.6. Vietnam Market Analysis

            16.8.6.1. Introduction

            16.8.6.2. Market Analysis and Forecast by Market Taxonomy

                16.8.6.2.1. By Modality

                16.8.6.2.2. By Application

                16.8.6.2.3. By End User

17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    17.1. Introduction / Key Findings

    17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Modality

        17.3.3. By Application

        17.3.4. By End User

    17.4. Market Attractiveness Analysis By Region

        17.4.1. By Country

        17.4.2. By Modality

        17.4.3. By Application

        17.4.4. By End User

    17.5. Market trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis and Forecast

        17.8.1. China Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Modality

                17.8.1.2.2. By Application

                17.8.1.2.3. By End User

        17.8.2. Japan Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Modality

                17.8.2.2.2. By Application

                17.8.2.2.3. By End User

        17.8.3. South Korea Market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast by Market Taxonomy

                17.8.3.2.1. By Modality

                17.8.3.2.2. By Application

                17.8.3.2.3. By End User

18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    18.1. Introduction / Key Findings

    18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Modality

        18.3.3. By Application

        18.3.4. By End User

    18.4. Market Attractiveness Analysis By Region

        18.4.1. By Country

        18.4.2. By Modality

        18.4.3. By Application

        18.4.4. By End User

    18.5. Market trends

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis and Forecast

        18.8.1. Australia Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Modality

                18.8.1.2.2. By Application

                18.8.1.2.3. By End User

        18.8.2. New Zealand Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Modality

                18.8.2.2.2. By Application

                18.8.2.2.3. By End User

19. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    19.1. Introduction / Key Findings

    19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Türkiye

            19.3.1.3. South Africa

            19.3.1.4. Northern Africa

            19.3.1.5. Rest of Middle East and Africa

        19.3.2. By Modality

        19.3.3. By Application

        19.3.4. By End User

    19.4. Market Attractiveness Analysis By Region

        19.4.1. By Country

        19.4.2. By Modality

        19.4.3. By Application

        19.4.4. By End User

    19.5. Market trends

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country Level Analysis and Forecast

        19.8.1. GCC Countries Market Analysis

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast by Market Taxonomy

                19.8.1.2.1. By Modality

                19.8.1.2.2. By Application

                19.8.1.2.3. By End User

        19.8.2. Türkiye Market Analysis

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast by Market Taxonomy

                19.8.2.2.1. By Modality

                19.8.2.2.2. By Application

                19.8.2.2.3. By End User

        19.8.3. South Africa Market Analysis

            19.8.3.1. Introduction

            19.8.3.2. Market Analysis and Forecast by Market Taxonomy

                19.8.3.2.1. By Modality

                19.8.3.2.2. By Application

                19.8.3.2.3. By End User

        19.8.4. Northern Africa Market Analysis

            19.8.4.1. Introduction

            19.8.4.2. Market Analysis and Forecast by Market Taxonomy

                19.8.4.2.1. By Modality

                19.8.4.2.2. By Application

                19.8.4.2.3. By End User

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Market Share Analysis of Top Players (%)

    20.3. Market Concentration

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Branding and Promotional Strategies, By Key Players

    21.3. Key Development Analysis

    21.4. Competition Deep Dive

        21.4.1. Koninklijke Philips N.V. (Netherlands)

            21.4.1.1. Overview

            21.4.1.2. Product Portfolio

            21.4.1.3. Key Financials

            21.4.1.4. Sales Footprint

            21.4.1.5. SWOT Analysis

            21.4.1.6. Strategy Overview

                21.4.1.6.1. Marketing Strategies

                21.4.1.6.2. Product Strategies

                21.4.1.6.3. Channel Strategies

        21.4.2. Hitachi Ltd. (Japan)

            21.4.2.1. Overview

            21.4.2.2. Product Portfolio

            21.4.2.3. Key Financials

            21.4.2.4. Sales Footprint

            21.4.2.5. SWOT Analysis

            21.4.2.6. Strategy Overview

                21.4.2.6.1. Marketing Strategies

                21.4.2.6.2. Product Strategies

                21.4.2.6.3. Channel Strategies

        21.4.3. Siemens Healthcare GmbH (Germany)

            21.4.3.1. Overview

            21.4.3.2. Product Portfolio

            21.4.3.3. Key Financials

            21.4.3.4. Sales Footprint

            21.4.3.5. SWOT Analysis

            21.4.3.6. Strategy Overview

                21.4.3.6.1. Marketing Strategies

                21.4.3.6.2. Product Strategies

                21.4.3.6.3. Channel Strategies

        21.4.4. CANON MEDICAL SYSTEMS CORPORATION (Japan)

            21.4.4.1. Overview

            21.4.4.2. Product Portfolio

            21.4.4.3. Key Financials

            21.4.4.4. Sales Footprint

            21.4.4.5. SWOT Analysis

            21.4.4.6. Strategy Overview

                21.4.4.6.1. Marketing Strategies

                21.4.4.6.2. Product Strategies

                21.4.4.6.3. Channel Strategies

        21.4.5. General Electric (US)

            21.4.5.1. Overview

            21.4.5.2. Product Portfolio

            21.4.5.3. Key Financials

            21.4.5.4. Sales Footprint

            21.4.5.5. SWOT Analysis

            21.4.5.6. Strategy Overview

                21.4.5.6.1. Marketing Strategies

                21.4.5.6.2. Product Strategies

                21.4.5.6.3. Channel Strategies

        21.4.6. Aspect Imaging Ltd (Israel)

            21.4.6.1. Overview

            21.4.6.2. Product Portfolio

            21.4.6.3. Key Financials

            21.4.6.4. Sales Footprint

            21.4.6.5. SWOT Analysis

            21.4.6.6. Strategy Overview

                21.4.6.6.1. Marketing Strategies

                21.4.6.6.2. Product Strategies

                21.4.6.6.3. Channel Strategies

        21.4.7. Bruker (US)

            21.4.7.1. Overview

            21.4.7.2. Product Portfolio

            21.4.7.3. Key Financials

            21.4.7.4. Sales Footprint

            21.4.7.5. SWOT Analysis

            21.4.7.6. Strategy Overview

                21.4.7.6.1. Marketing Strategies

                21.4.7.6.2. Product Strategies

                21.4.7.6.3. Channel Strategies

        21.4.8. Aurora Health Care (US)

            21.4.8.1. Overview

            21.4.8.2. Product Portfolio

            21.4.8.3. Key Financials

            21.4.8.4. Sales Footprint

            21.4.8.5. SWOT Analysis

            21.4.8.6. Strategy Overview

                21.4.8.6.1. Marketing Strategies

                21.4.8.6.2. Product Strategies

                21.4.8.6.3. Channel Strategies

        21.4.9. FONAR Corp. (US)

            21.4.9.1. Overview

            21.4.9.2. Product Portfolio

            21.4.9.3. Key Financials

            21.4.9.4. Sales Footprint

            21.4.9.5. SWOT Analysis

            21.4.9.6. Strategy Overview

                21.4.9.6.1. Marketing Strategies

                21.4.9.6.2. Product Strategies

                21.4.9.6.3. Channel Strategies

        21.4.10. ESAOTE SPA (Italy)

            21.4.10.1. Overview

            21.4.10.2. Product Portfolio

            21.4.10.3. Key Financials

            21.4.10.4. Sales Footprint

            21.4.10.5. SWOT Analysis

            21.4.10.6. Strategy Overview

                21.4.10.6.1. Marketing Strategies

                21.4.10.6.2. Product Strategies

                21.4.10.6.3. Channel Strategies

        21.4.11. Neusoft Corporation (China)

            21.4.11.1. Overview

            21.4.11.2. Product Portfolio

            21.4.11.3. Key Financials

            21.4.11.4. Sales Footprint

            21.4.11.5. SWOT Analysis

            21.4.11.6. Strategy Overview

                21.4.11.6.1. Marketing Strategies

                21.4.11.6.2. Product Strategies

                21.4.11.6.3. Channel Strategies

        21.4.12. TOSHIBA CORPORATION (Japan)

            21.4.12.1. Overview

            21.4.12.2. Product Portfolio

            21.4.12.3. Key Financials

            21.4.12.4. Sales Footprint

            21.4.12.5. SWOT Analysis

            21.4.12.6. Strategy Overview

                21.4.12.6.1. Marketing Strategies

                21.4.12.6.2. Product Strategies

                21.4.12.6.3. Channel Strategies

        21.4.13. Sanrad Medical Systems Private Limited (India)

            21.4.13.1. Overview

            21.4.13.2. Product Portfolio

            21.4.13.3. Key Financials

            21.4.13.4. Sales Footprint

            21.4.13.5. SWOT Analysis

            21.4.13.6. Strategy Overview

                21.4.13.6.1. Marketing Strategies

                21.4.13.6.2. Product Strategies

                21.4.13.6.3. Channel Strategies

        21.4.14. FUJIFILM Holdings Corporation (Japan)

            21.4.14.1. Overview

            21.4.14.2. Product Portfolio

            21.4.14.3. Key Financials

            21.4.14.4. Sales Footprint

            21.4.14.5. SWOT Analysis

            21.4.14.6. Strategy Overview

                21.4.14.6.1. Marketing Strategies

                21.4.14.6.2. Product Strategies

                21.4.14.6.3. Channel Strategies

        21.4.15. ONEX Corporation (Canada)

            21.4.15.1. Overview

            21.4.15.2. Product Portfolio

            21.4.15.3. Key Financials

            21.4.15.4. Sales Footprint

            21.4.15.5. SWOT Analysis

            21.4.15.6. Strategy Overview

                21.4.15.6.1. Marketing Strategies

                21.4.15.6.2. Product Strategies

                21.4.15.6.3. Channel Strategies

        21.4.16. Hologic, Inc. (US)

            21.4.16.1. Overview

            21.4.16.2. Product Portfolio

            21.4.16.3. Key Financials

            21.4.16.4. Sales Footprint

            21.4.16.5. SWOT Analysis

            21.4.16.6. Strategy Overview

                21.4.16.6.1. Marketing Strategies

                21.4.16.6.2. Product Strategies

                21.4.16.6.3. Channel Strategies

        21.4.17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)

            21.4.17.1. Overview

            21.4.17.2. Product Portfolio

            21.4.17.3. Key Financials

            21.4.17.4. Sales Footprint

            21.4.17.5. SWOT Analysis

            21.4.17.6. Strategy Overview

                21.4.17.6.1. Marketing Strategies

                21.4.17.6.2. Product Strategies

                21.4.17.6.3. Channel Strategies

        21.4.18. Imaging Diagnostic Systems, Inc. (US)

            21.4.18.1. Overview

            21.4.18.2. Product Portfolio

            21.4.18.3. Key Financials

            21.4.18.4. Sales Footprint

            21.4.18.5. SWOT Analysis

            21.4.18.6. Strategy Overview

                21.4.18.6.1. Marketing Strategies

                21.4.18.6.2. Product Strategies

                21.4.18.6.3. Channel Strategies

        21.4.19. Agfa-Gevaert Group (Belgium)

            21.4.19.1. Overview

            21.4.19.2. Product Portfolio

            21.4.19.3. Key Financials

            21.4.19.4. Sales Footprint

            21.4.19.5. SWOT Analysis

            21.4.19.6. Strategy Overview

                21.4.19.6.1. Marketing Strategies

                21.4.19.6.2. Product Strategies

                21.4.19.6.3. Channel Strategies

        21.4.20. Koning Health (China)

            21.4.20.1. Overview

            21.4.20.2. Product Portfolio

            21.4.20.3. Key Financials

            21.4.20.4. Sales Footprint

            21.4.20.5. SWOT Analysis

            21.4.20.6. Strategy Overview

                21.4.20.6.1. Marketing Strategies

                21.4.20.6.2. Product Strategies

                21.4.20.6.3. Channel Strategies

22. Assumptions and Acronyms Used

23. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 01: Global Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 02: Global Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 03: Global Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application

Table 04: Global Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By End User

Table 05: Global Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Region

Table 06: Global Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Region

Table 07: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

Table 08: North America Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 09: North America Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 10: North America Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application

Table 11: North America Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User

Table 12: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

Table 13: Latin America Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 14: Latin America Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 15: Latin America Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application

Table 16: Latin America Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User

Table 17: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

Table 18: Europe Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 19: Europe Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 20: Europe Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application

Table 21: Europe Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User

Table 22: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

Table 23: South Asia Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 24: South Asia Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 25: South Asia Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application

Table 26: South Asia Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User

Table 27: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

Table 28: East Asia Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 29: East Asia Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 30: East Asia Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application

Table 31: East Asia Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User

Table 32: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

Table 33: Oceania Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 34: Oceania Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 35: Oceania Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application

Table 36: Oceania Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User

Table 37: Middle East and Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

Table 38: Middle East and Africa Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 39: Middle East and Africa Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality

Table 40: Middle East and Africa Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application

Table 41: Middle East and Africa Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 01: Global Market Value Share, By Modality, 2023 (E)

Figure 02: Global Market Value Share, By Application, 2023 (E)

Figure 03: Global Market Value Share, By End User, 2023 (E)

Figure 04: Global Market Value Share, By Region, 2023 (E)

Figure 05: Global Market Volume Analysis (US$ Million), 2017 to 2022

Figure 06: Global Market Volume Forecast (US$ Million), 2023 to 2033

Figure 07: Single Head Gamma Camera, Average Selling Price by Region, Per Unit (US$), 2022

Figure 08: Single Head Gamma Camera, Average Selling Price by Region, Per Unit (US$), 2033

Figure 09: Dual Head Camera, Average Selling Price by Region, Per Unit (US$), 2022

Figure 10: Dual Head Camera, Average Selling Price by Region, Per Unit (US$), 2033

Figure 11: Global Market Value Analysis (US$ Million), 2017 to 2022

Figure 12: Global Market Value Forecast (US$ Million), 2023 to 2033

Figure 13: Global Market Absolute $ Opportunity, 2023 to 2033

Figure 14: Global Market Share Analysis (%), By Modality, 2023 and 2033

Figure 15: Global Market Y-o-Y Analysis (%), By Modality, 2023 to 2033

Figure 16: Global Market Attractiveness Analysis by Modality, 2023 to 2033

Figure 17: Global Market Share Analysis (%), By Application, 2023 and 2033

Figure 18: Global Market Y-o-Y Analysis (%), By Application, 2023 to 2033

Figure 19: Global Market Attractiveness Analysis by Application, 2023 to 2033

Figure 20: Global Market Share Analysis (%), By End User, 2023 and 2033

Figure 21: Global Market Y-o-Y Analysis (%), By End User, 2023 to 2033

Figure 22: Global Market Attractiveness Analysis by End User, 2023 to 2033

Figure 23: Global Market Share Analysis (%), By Region, 2023 and 2033

Figure 24: Global Market Y-o-Y Analysis (%), By Region, 2023 to 2033

Figure 25: Global Market Attractiveness Analysis by Region, 2023 to 2033

Figure 26: North America Market Value Share, By Modality, 2023 (E)

Figure 27: North America Market Value Share, By Application, 2023 (E)

Figure 28: North America Market Value Share, By End User, 2023 (E)

Figure 29: North America Market Value Share, By Country, 2023 (E)

Figure 30: North America Market Value Analysis (US$ Million), 2017 to 2022

Figure 31: North America Market Value Forecast (US$ Million), 2023 to 2033

Figure 32: North America Market Attractiveness Analysis by Modality, 2023 to 2033

Figure 33: North America Market Attractiveness Analysis by Application, 2023 to 2033

Figure 34: North America Market Attractiveness Analysis by End User, 2023 to 2033

Figure 35: North America Market Attractiveness Analysis by Country, 2023 to 2033

Figure 36: United States Market Value Proportion Analysis, 2022

Figure 37: Global Vs. United States Growth Comparison, 2022 to 2033

Figure 38: United States Market Share Analysis (%) By Modality, 2022 and 2033

Figure 39: United States Market Share Analysis (%) By Application, 2022 and 2033

Figure 40: United States Market Share Analysis (%) By End User, 2022 and 2033

Figure 41: Canada Market Value Proportion Analysis, 2022

Figure 42: Global Vs. Canada. Growth Comparison, 2022 to 2033

Figure 43: Canada Market Share Analysis (%) By Modality, 2022 and 2033

Figure 44: Canada Market Share Analysis (%) By Application, 2022 and 2033

Figure 45: Canada Market Share Analysis (%) By End User, 2022 and 2033

Figure 46: Latin America Market Value Share, By Modality, 2023 (E)

Figure 47: Latin America Market Value Share, By Application, 2023 (E)

Figure 48: Latin America Market Value Share, By End User, 2023 (E)

Figure 49: Latin America Market Value Share, By Country, 2023 (E)

Figure 50: Latin America Market Value Analysis (US$ Million), 2017 to 2022

Figure 51: Latin America Market Value Forecast (US$ Million), 2023 to 2033

Figure 52: Latin America Market Attractiveness Analysis by Modality, 2023 to 2033

Figure 53: Latin America Market Attractiveness Analysis by Application, 2023 to 2033

Figure 54: Latin America Market Attractiveness Analysis by End User, 2023 to 2033

Figure 55: Latin America Market Attractiveness Analysis by Country, 2023 to 2033

Figure 56: Mexico Market Value Proportion Analysis, 2022

Figure 57: Global Vs Mexico Growth Comparison, 2022 to 2033

Figure 58: Mexico Market Share Analysis (%) By Modality, 2022 and 2033

Figure 59: Mexico Market Share Analysis (%) By Application, 2022 and 2033

Figure 60: Mexico Market Share Analysis (%) By End User, 2022 and 2033

Figure 61: Brazil Market Value Proportion Analysis, 2022

Figure 62: Global Vs. Brazil. Growth Comparison, 2022 to 2033

Figure 63: Brazil Market Share Analysis (%) By Modality, 2022 and 2033

Figure 64: Brazil Market Share Analysis (%) By Application, 2022 and 2033

Figure 65: Brazil Market Share Analysis (%) By End User, 2022 and 2033

Figure 66: Argentina Market Value Proportion Analysis, 2022

Figure 67: Global Vs Argentina Growth Comparison, 2022 to 2033

Figure 68: Argentina Market Share Analysis (%) By Modality, 2022 and 2033

Figure 69: Argentina Market Share Analysis (%) By Application, 2022 and 2033

Figure 70: Argentina Market Share Analysis (%) By End User, 2022 and 2033

Figure 71: Europe Market Value Share, By Modality, 2023 (E)

Figure 72: Europe Market Value Share, By Application, 2023 (E)

Figure 73: Europe Market Value Share, By End User, 2023 (E)

Figure 74: Europe Market Value Share, By Country, 2023 (E)

Figure 75: Europe Market Value Analysis (US$ Million), 2017 to 2022

Figure 76: Europe Market Value Forecast (US$ Million), 2023 to 2033

Figure 77: Europe Market Attractiveness Analysis by Modality, 2023 to 2033

Figure 78: Europe Market Attractiveness Analysis by Application, 2023 to 2033

Figure 79: Europe Market Attractiveness Analysis by End User, 2023 to 2033

Figure 80: Europe Market Attractiveness Analysis by Country, 2023 to 2033

Figure 81: United Kingdom Market Value Proportion Analysis, 2022

Figure 82: Global Vs. United Kingdom Growth Comparison, 2022 to 2033

Figure 83: United Kingdom Market Share Analysis (%) By Modality, 2022 and 2033

Figure 84: United Kingdom Market Share Analysis (%) By Application, 2022 and 2033

Figure 85: United Kingdom Market Share Analysis (%) By End User, 2022 and 2033

Figure 86: Germany Market Value Proportion Analysis, 2022

Figure 87: Global Vs. Germany Growth Comparison, 2022 to 2033

Figure 88: Germany Market Share Analysis (%) By Modality, 2022 and 2033

Figure 89: Germany Market Share Analysis (%) By Application, 2022 and 2033

Figure 90: Germany Market Share Analysis (%) By End User, 2022 and 2033

Figure 91: Italy Market Value Proportion Analysis, 2022

Figure 92: Global Vs. Italy Growth Comparison, 2022 to 2033

Figure 93: Italy Market Share Analysis (%) By Modality, 2022 and 2033

Figure 94: Italy Market Share Analysis (%) By Application, 2022 and 2033

Figure 95: Italy Market Share Analysis (%) By End User, 2022 and 2033

Figure 96: France Market Value Proportion Analysis, 2022

Figure 97: Global Vs France Growth Comparison, 2022 to 2033

Figure 98: France Market Share Analysis (%) By Modality, 2022 and 2033

Figure 99: France Market Share Analysis (%) By Application, 2022 and 2033

Figure 100: France Market Share Analysis (%) By End User, 2022 and 2033

Figure 101: Spain Market Value Proportion Analysis, 2022

Figure 102: Global Vs Spain Growth Comparison, 2022 to 2033

Figure 103: Spain Market Share Analysis (%) By Modality, 2022 and 2033

Figure 104: Spain Market Share Analysis (%) By Application, 2022 and 2033

Figure 105: Spain Market Share Analysis (%) By End User, 2022 and 2033

Figure 106: Russia Market Value Proportion Analysis, 2022

Figure 107: Global Vs Russia Growth Comparison, 2022 to 2033

Figure 108: Russia Market Share Analysis (%) By Modality, 2022 and 2033

Figure 109: Russia Market Share Analysis (%) By Application, 2022 and 2033

Figure 110: Russia Market Share Analysis (%) By End User, 2022 and 2033

Figure 111: Benelux Market Value Proportion Analysis, 2022

Figure 112: Global Vs Benelux Growth Comparison, 2022 to 2033

Figure 113: Benelux Market Share Analysis (%) By Modality, 2022 and 2033

Figure 114: Benelux Market Share Analysis (%) By Application, 2022 and 2033

Figure 115: Benelux Market Share Analysis (%) By End User, 2022 and 2033

Figure 116: Nordics Market Value Proportion Analysis, 2022

Figure 117: Global Vs Nordics Growth Comparison, 2022 to 2033

Figure 118: Nordics Market Share Analysis (%) By Modality, 2022 and 2033

Figure 119: Nordics Market Share Analysis (%) By Application, 2022 and 2033

Figure 120: Nordics Market Share Analysis (%) By End User, 2022 and 2033

Figure 121: South Asia Market Value Share, By Modality, 2023 (E)

Figure 122: South Asia Market Value Share, By Application, 2023 (E)

Figure 123: South Asia Market Value Share, By End User, 2023 (E)

Figure 124: South Asia Market Value Share, By Country, 2023 (E)

Figure 125: South Asia Market Value Analysis (US$ Million), 2017 to 2022

Figure 126: South Asia Market Value Forecast (US$ Million), 2023 to 2033

Figure 127: South Asia Market Attractiveness Analysis by Modality, 2023 to 2033

Figure 128: South Asia Market Attractiveness Analysis by Application, 2023 to 2033

Figure 129: South Asia Market Attractiveness Analysis by End User, 2023 to 2033

Figure 130: South Asia Market Attractiveness Analysis by Country, 2023 to 2033

Figure 131: India Market Value Proportion Analysis, 2022

Figure 132: Global Vs. India Growth Comparison, 2022 to 2033

Figure 133: India Market Share Analysis (%) By Modality, 2022 and 2033

Figure 134: India Market Share Analysis (%) By Application, 2022 and 2033

Figure 135: India Market Share Analysis (%) By End User, 2022 and 2033

Figure 136: Indonesia Market Value Proportion Analysis, 2022

Figure 137: Global Vs. Indonesia Growth Comparison, 2022 to 2033

Figure 138: Indonesia Market Share Analysis (%) By Modality, 2022 and 2033

Figure 139: Indonesia Market Share Analysis (%) By Application, 2022 and 2033

Figure 140: Indonesia Market Share Analysis (%) By End User, 2022 and 2033

Figure 141: Malaysia Market Value Proportion Analysis, 2022

Figure 142: Global Vs. Malaysia Growth Comparison, 2022 to 2033

Figure 143: Malaysia Market Share Analysis (%) By Modality, 2022 and 2033

Figure 144: Malaysia Market Share Analysis (%) By Application, 2022 and 2033

Figure 145: Malaysia Market Share Analysis (%) By End User, 2022 and 2033

Figure 146: Thailand Market Value Proportion Analysis, 2022

Figure 147: Global Vs. Thailand Growth Comparison, 2022 to 2033

Figure 148: Thailand Market Share Analysis (%) By Modality, 2022 and 2033

Figure 149: Thailand Market Share Analysis (%) By Application, 2022 and 2033

Figure 150: Thailand Market Share Analysis (%) By End User, 2022 and 2033

Figure 151: Philippines Market Value Proportion Analysis, 2022

Figure 152: Global Vs. Philippines Growth Comparison, 2022 to 2033

Figure 153: Philippines Market Share Analysis (%) By Modality, 2022 and 2033

Figure 154: Philippines Market Share Analysis (%) By Application, 2022 and 2033

Figure 155: Philippines Market Share Analysis (%) By End User, 2022 and 2033

Figure 156: Vietnam Market Value Proportion Analysis, 2022

Figure 157: Global Vs. Vietnam Growth Comparison, 2022 to 2033

Figure 158: Vietnam Market Share Analysis (%) By Modality, 2022 and 2033

Figure 159: Vietnam Market Share Analysis (%) By Application, 2022 and 2033

Figure 160: Vietnam Market Share Analysis (%) By End User, 2022 and 2033

Figure 161: East Asia Market Value Share, By Modality, 2023 (E)

Figure 162: East Asia Market Value Share, By Application, 2023 (E)

Figure 163: East Asia Market Value Share, By End User, 2023 (E)

Figure 164: East Asia Market Value Share, By Country, 2023 (E)

Figure 165: East Asia Market Value Analysis (US$ Million), 2017 to 2022

Figure 166: East Asia Market Value Forecast (US$ Million), 2023 to 2033

Figure 167: East Asia Market Attractiveness Analysis by Modality, 2023 to 2033

Figure 168: East Asia Market Attractiveness Analysis by Application, 2023 to 2033

Figure 169: East Asia Market Attractiveness Analysis by End User, 2023 to 2033

Figure 170: East Asia Market Attractiveness Analysis by Country, 2023 to 2033

Figure 171: China Market Value Proportion Analysis, 2022

Figure 172: Global Vs. China Growth Comparison, 2022 to 2033

Figure 173: China Market Share Analysis (%) By Modality, 2022 and 2033

Figure 174: China Market Share Analysis (%) By Application, 2022 and 2033

Figure 175: China Market Share Analysis (%) By End User, 2022 and 2033

Figure 176: Japan Market Value Proportion Analysis, 2022

Figure 177: Global Vs. Japan Growth Comparison, 2022 to 2033

Figure 178: Japan Market Share Analysis (%) By Modality, 2022 and 2033

Figure 179: Japan Market Share Analysis (%) By Application, 2022 and 2033

Figure 180: Japan Market Share Analysis (%) By End User, 2022 and 2033

Figure 181: South Korea Market Value Proportion Analysis, 2022

Figure 182: Global Vs South Korea Growth Comparison, 2022 to 2033

Figure 183: South Korea Market Share Analysis (%) By Modality, 2022 and 2033

Figure 184: South Korea Market Share Analysis (%) By Application, 2022 and 2033

Figure 185: South Korea Market Share Analysis (%) By End User, 2022 and 2033

Figure 186: Oceania Market Value Share, By Modality, 2023 (E)

Figure 187: Oceania Market Value Share, By Application, 2023 (E)

Figure 188: Oceania Market Value Share, By End User, 2023 (E)

Figure 189: Oceania Market Value Share, By Country, 2023 (E)

Figure 190: Oceania Market Value Analysis (US$ Million), 2017 to 2022

Figure 191: Oceania Market Value Forecast (US$ Million), 2023 to 2033

Figure 192: Oceania Market Attractiveness Analysis by Modality, 2023 to 2033

Figure 193: Oceania Market Attractiveness Analysis by Application, 2023 to 2033

Figure 194: Oceania Market Attractiveness Analysis by End User, 2023 to 2033

Figure 195: Oceania Market Attractiveness Analysis by Country, 2023 to 2033

Figure 196: Australia Market Value Proportion Analysis, 2022

Figure 197: Global Vs. Australia Growth Comparison, 2022 to 2033

Figure 198: Australia Market Share Analysis (%) By Modality, 2022 and 2033

Figure 199: Australia Market Share Analysis (%) By Application, 2022 and 2033

Figure 200: Australia Market Share Analysis (%) By End User, 2022 and 2033

Figure 201: New Zealand Market Value Proportion Analysis, 2022

Figure 202: Global Vs New Zealand Growth Comparison, 2022 to 2033

Figure 203: New Zealand Market Share Analysis (%) By Modality, 2022 and 2033

Figure 204: New Zealand Market Share Analysis (%) By Application, 2022 and 2033

Figure 205: New Zealand Market Share Analysis (%) By End User, 2022 and 2033

Figure 206: Middle East and Africa Market Value Share, By Modality, 2023 (E)

Figure 207: Middle East and Africa Market Value Share, By Application, 2023 (E)

Figure 208: Middle East and Africa Market Value Share, By End User, 2023 (E)

Figure 209: Middle East and Africa Market Value Share, By Country, 2023 (E)

Figure 210: Middle East and Africa Market Value Analysis (US$ Million), 2017 to 2022

Figure 211: Middle East and Africa Market Value Forecast (US$ Million), 2023 to 2033

Figure 212: Middle East and Africa Market Attractiveness Analysis by Modality, 2023 to 2033

Figure 213: Middle East and Africa Market Attractiveness Analysis by Application, 2023 to 2033

Figure 214: Middle East and Africa Market Attractiveness Analysis by End User, 2023 to 2033

Figure 215: Middle East and Africa Market Attractiveness Analysis by Country, 2023 to 2033

Figure 216: GCC Countries Market Value Proportion Analysis, 2022

Figure 217: Global Vs GCC Countries Growth Comparison, 2022 to 2033

Figure 218: GCC Countries Market Share Analysis (%) By Modality, 2022 and 2033

Figure 219: GCC Countries Market Share Analysis (%) By Application, 2022 and 2033

Figure 220: GCC Countries Market Share Analysis (%) By End User, 2022 and 2033

Figure 221: Türkiye Market Value Proportion Analysis, 2022

Figure 222: Global Vs. Türkiye Growth Comparison, 2022 to 2033

Figure 223: Türkiye Market Share Analysis (%) By Modality, 2022 and 2033

Figure 224: Türkiye Market Share Analysis (%) By Application, 2022 and 2033

Figure 225: Türkiye Market Share Analysis (%) By End User, 2022 and 2033

Figure 226: South Africa Market Value Proportion Analysis, 2022

Figure 227: Global Vs. South Africa Growth Comparison, 2022 to 2033

Figure 228: South Africa Market Share Analysis (%) By Modality, 2022 and 2033

Figure 229: South Africa Market Share Analysis (%) By Application, 2022 and 2033

Figure 230: South Africa Market Share Analysis (%) By End User, 2022 and 2033

Figure 231: Northern Africa Market Value Proportion Analysis, 2022

Figure 232: Global Vs Northern Africa Growth Comparison, 2022 to 2033

Figure 233: Northern Africa Market Share Analysis (%) By Modality, 2022 and 2033

Figure 234: Northern Africa Market Share Analysis (%) By Application, 2022 and 2033

Figure 235: Northern Africa Market Share Analysis (%) By End User, 2022 and 2033

Recommendations

Healthcare

Breast Cancer Drug Market

Published : July 2023

Healthcare

Breast Biopsy Devices Market

Published : October 2022

Healthcare

Breast Lesion Localization Device Market

Published : May 2022

Explore Healthcare Insights

View Reports

Molecular Breast Imaging Market